SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers
Clinical trial NCT07080619 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07080619
- Sponsor
- Tianjin ConjuStar Biologics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-20
- Primary completion
- 2027-07-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.